NewAmsterdam Pharma Company N.V. (NAMSW) Capital expenditures 2021–2025
NewAmsterdam Pharma Company N.V. (NAMSW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$246,000FY2025 · since FY2021: $24,000 → $246,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $246,000 | -63.4% |
| FY2024 | $672,000 | +2700.0% |
| FY2023 | $24,000 | -89.1% |
| FY2022 | $221,000 | +820.8% |
| FY2021 | $24,000 | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice
More NAMSW financial trends
NAMSW RevenueNAMSW Net incomeNAMSW Net marginNAMSW Gross profitNAMSW Gross marginNAMSW Operating incomeNAMSW Operating marginNAMSW Operating cash flowNAMSW Free cash flowNAMSW Return on equityNAMSW Stock buybacksNAMSW Dividends paidNAMSW Total assetsNAMSW Total liabilitiesNAMSW Shareholders’ equityNAMSW overview →